Evidence map›Paper›PMID 32164781›Full record

Trial reportRadiation oncology (London, England)2020

Indications, feasibility, safety, and efficacy of CyberKnife radiotherapy for the treatment of olfactory groove meningiomas: a single institutional retrospective series.

Jianmin Liu, Rafael Rojas, Fred C Lam, Farhan A Mirza, Anand Mahadevan, Ekkehard M Kasper

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Radiation oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianmin LiuDepartment of Neurosurgery, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Rafael RojasDepartment of Radiology, Division of Neuroradiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Fred C LamDivision of Neurosurgery, Department of Surgery, Hamilton General Hospital, McMaster University Faculty of Health Sciences, 237 Barton Street East, Hamilton, ON, L2L 8X8, Canada.
Farhan A MirzaDivision of Neurosurgery, Kentucky Neuroscience Institute, University of Kentucky, Lexington, KT, USA.
Anand MahadevanDepartment of Radiation Oncology, Geisinger Medical Group, Danville, PA, USA.
Ekkehard M KasperDepartment of Radiology, Division of Neuroradiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. kaspere@mcmaster.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the safety and efficacy of CyberKnife® radiotherapy (CKRT) for the treatment of olfactory groove meningiomas (OGMs).

methodsA retrospective review was performed of 13 patients with OGM treated with CKRT from September 2005 to May 2018 at our institution. Nine patients were treated primarily with CKRT, 3 for residual disease following resection, and 1 for disease recurrence.

resultsFive patients were treated with stereotactic radiosurgery (SRS), 6 with hypofractionated stereotactic radiotherapy (HSRT), and 2 with fractionated stereotactic radiotherapy (FSRT). The median tumor volume was 8.12 cm

conclusionsCKRT appears to be safe and effective for the treatment of OGMs.

Indexed as

Radiation Dose HypofractionationAgedAged, 80 and overFeasibility StudiesFemaleHumansMaleMeningeal NeoplasmsMeningiomaMiddle AgedPrognosisRadiosurgeryRadiotherapy DosageRadiotherapy, Intensity-ModulatedRetrospective StudiesSurvival RateCyberKnife radiotherapyFractionated stereotactic radiotherapy; Hypofractionated stereotactic radiotherapyOlfactory groove meningiomasStereotactic radiosurgery

Identifiers

PMID32164781
PMCPMC7069021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.